TG Therapeutics Raises FY2026 Sales Guidance from $950.000M to $1.000B vs $960.306M Est
Benzinga Newsdesk 1 hour ago
NewsGuidance
TG Therapeutics (NASDAQ:TGTX) raises FY2026 sales outlook from $950.000 million to $1.000 billion vs $960.306 million estimate.
TG Therapeutics (NASDAQ:TGTX) raises FY2026 sales outlook from $950.000 million to $1.000 billion vs $960.306 million estimate.